Literature DB >> 21143412

Post-translational inactivation of endothelial nitric oxide synthase in the transgenic sickle cell mouse penis.

Biljana Musicki1, Hunter C Champion, Lewis L Hsu, Trinity J Bivalacqua, Arthur L Burnett.   

Abstract

INTRODUCTION: Sickle cell disease (SCD)-associated priapism is characterized by endothelial nitric oxide synthase (eNOS) dysfunction in the penis. However, the mechanism of decreased eNOS function/activation in the penis in association with SCD is not known. AIMS: Our hypothesis in the present study was that eNOS is functionally inactivated in the SCD penis in association with impairments in eNOS post-translational phosphorylation and the enzyme's interactions with its regulatory proteins.
METHODS: Sickle cell transgenic (sickle) mice were used as an animal model of SCD. Wild-type (WT) mice served as controls. Penes were excised at baseline for molecular studies. eNOS phosphorylation on Ser-1177 (positive regulatory site) and Thr-495 (negative regulatory site), total eNOS, and phosphorylated AKT (upstream mediator of eNOS phosphorylation on Ser-1177) expressions, and eNOS interactions with heat-shock protein 90 (HSP90) and caveolin-1 were measured by Western blot. Constitutive NOS catalytic activity was measured by conversion of L-[14C]arginine-to-L-[14C]citrulline in the presence of calcium. MAIN OUTCOME MEASURES: Molecular mechanisms of eNOS dysfunction in the sickle mouse penis.
RESULTS: eNOS phosphorylated on Ser-1177, an active portion of eNOS, was decreased in the sickle mouse penis compared with WT penis. eNOS interaction with its positive protein regulator HSP90, but not with its negative protein regulator caveolin-1, and phosphorylated AKT expression, as well as constitutive NOS activity, were also decreased in the sickle mouse penis compared with WT penis. eNOS phosphorylated on Thr-495, total eNOS, HSP90, and caveolin-1 protein expressions in the penis were not affected by SCD.
CONCLUSIONS: These findings provide a molecular basis for chronically reduced eNOS function in the penis by SCD, which involves decreased eNOS phosphorylation on Ser-1177 and decreased eNOS-HSP90 interaction.
© 2010 International Society for Sexual Medicine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21143412      PMCID: PMC5497993          DOI: 10.1111/j.1743-6109.2010.02123.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  45 in total

1.  Heat shock proteins 70 and 90 increase calcineurin activity in vitro through calmodulin-dependent and independent mechanisms.

Authors:  J S Someren; L E Faber; J D Klein; J A Tumlin
Journal:  Biochem Biophys Res Commun       Date:  1999-07-14       Impact factor: 3.575

2.  Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase.

Authors:  K A Pritchard; A W Ackerman; E R Gross; D W Stepp; Y Shi; J T Fontana; J E Baker; W C Sessa
Journal:  J Biol Chem       Date:  2001-03-16       Impact factor: 5.157

3.  Endothelial nitric oxide synthase keeps erection regulatory function balance in the penis.

Authors:  Trinity J Bivalacqua; Tongyun Liu; Biljana Musicki; Hunter C Champion; Arthur L Burnett
Journal:  Eur Urol       Date:  2006-11-10       Impact factor: 20.096

4.  Modulation of Akt kinase activity by binding to Hsp90.

Authors:  S Sato; N Fujita; T Tsuruo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

5.  Post-translational regulation of endothelial nitric oxide synthase (eNOS) by estrogens in the rat vagina.

Authors:  Biljana Musicki; Tongyun Liu; Travis D Strong; Gwen A Lagoda; Trinity J Bivalacqua; Arthur L Burnett
Journal:  J Sex Med       Date:  2010-03-11       Impact factor: 3.802

6.  Synergistic activation of endothelial nitric-oxide synthase (eNOS) by HSP90 and Akt: calcium-independent eNOS activation involves formation of an HSP90-Akt-CaM-bound eNOS complex.

Authors:  Satoru Takahashi; Michael E Mendelsohn
Journal:  J Biol Chem       Date:  2003-06-10       Impact factor: 5.157

7.  Heat shock protein 90 and tyrosine kinase regulate eNOS NO* generation but not NO* bioactivity.

Authors:  Jingsong Ou; Jason T Fontana; Zhijun Ou; Deron W Jones; Allan W Ackerman; Keith T Oldham; Jun Yu; William C Sessa; Kirkwood A Pritchard
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-10-09       Impact factor: 4.733

8.  Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling.

Authors:  Tiejuan Mi; Shahrzad Abbasi; Hong Zhang; Karen Uray; Janci L Chunn; Ling Wei Xia; Jose G Molina; Norman W Weisbrodt; Rodney E Kellems; Michael R Blackburn; Yang Xia
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

Review 9.  Life history of eNOS: partners and pathways.

Authors:  David M Dudzinski; Thomas Michel
Journal:  Cardiovasc Res       Date:  2007-04-03       Impact factor: 10.787

Review 10.  Posttranslational modification of constitutive nitric oxide synthase in the penis.

Authors:  Biljana Musicki; Ashley E Ross; Hunter C Champion; Arthur L Burnett; Trinity J Bivalacqua
Journal:  J Androl       Date:  2009-04-02
View more
  10 in total

Review 1.  Molecular pathophysiology of priapism: emerging targets.

Authors:  Uzoma A Anele; Belinda F Morrison; Arthur L Burnett
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

Review 2.  Stuttering priapism: insights into pathogenesis and management.

Authors:  Belinda F Morrison; Arthur L Burnett
Journal:  Curr Urol Rep       Date:  2012-08       Impact factor: 3.092

3.  Targeting NADPH oxidase decreases oxidative stress in the transgenic sickle cell mouse penis.

Authors:  Biljana Musicki; Tongyun Liu; Sena F Sezen; Arthur L Burnett
Journal:  J Sex Med       Date:  2012-05-23       Impact factor: 3.802

4.  Testosterone replacement in transgenic sickle cell mice controls priapic activity and upregulates PDE5 expression and eNOS activity in the penis.

Authors:  B Musicki; S Karakus; W Akakpo; F H Silva; J Liu; H Chen; B R Zirkin; A L Burnett
Journal:  Andrology       Date:  2017-11-16       Impact factor: 3.842

5.  Sildenafil promotes eNOS activation and inhibits NADPH oxidase in the transgenic sickle cell mouse penis.

Authors:  Biljana Musicki; Trinity J Bivalacqua; Hunter C Champion; Arthur L Burnett
Journal:  J Sex Med       Date:  2013-11-20       Impact factor: 3.802

6.  Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism.

Authors:  Gwen Lagoda; Sena F Sezen; K Joseph Hurt; Marcelo R Cabrini; Dillip K Mohanty; Arthur L Burnett
Journal:  FASEB J       Date:  2013-09-27       Impact factor: 5.191

7.  Molecular analysis of erection regulatory factors in sickle cell disease associated priapism in the human penis.

Authors:  Gwen Lagoda; Sena F Sezen; Marcelo R Cabrini; Biljana Musicki; Arthur L Burnett
Journal:  J Urol       Date:  2012-10-08       Impact factor: 7.450

8.  Subacute Hemolysis in Sickle Cell Mice Causes Priapism Secondary to NO Imbalance and PDE5 Dysregulation.

Authors:  Nikolai A Sopko; Hotaka Matsui; Johanna L Hannan; Dan Berkowitz; Hunter C Champion; Lewis L Hsu; Biljana Musicki; Arthur L Burnett; Trinity J Bivalacqua
Journal:  J Sex Med       Date:  2015-09-07       Impact factor: 3.802

Review 9.  Gas what: NO is not the only answer to sexual function.

Authors:  G Yetik-Anacak; R Sorrentino; A E Linder; N Murat
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

10.  Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative/nitrosative stress.

Authors:  Trinity J Bivalacqua; Biljana Musicki; Lewis L Hsu; Dan E Berkowitz; Hunter C Champion; Arthur L Burnett
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.